Purchase Order 36C24225P1120
Award Date
6/20/25
Potential Completion Date
6/23/25
Potential Value
$11K
Federal Agency
Veterans Integrated Service Network 2
Awardee
Pantherx Specialty, LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Pittsburgh, PA 15205, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price purchase order contract awarded by the Department of Veterans Affairs Veterans Health Administration (VA VHA) to Pantherx Specialty, LLC, a specialty pharmacy subsidiary of Centene Corporation. The contract is for the supply of the prescription medication Tarpeyo 4mg capsules to VA facilities within Veterans Integrated Service Network 2. The contract has a total ceiling value of $10,638.00 and runs through March 20, 2025. There is no set-aside designation associated...
This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. The contract is for the supply of TARPEYO (budesonide) 4mg prescription medication to the VA's Veterans Integrated Service Network (VISN) 2, which serves the New York Harbor region. The total ceiling value of the contract is $10,897.20, with a period of performance through May 2, 2025. The contract...
This federal contract award, valued at $10,897.20, was issued by the Veterans Integrated Service Network 2 (VISN 2) of the Department of Veterans Affairs (VA) to Pantherx Specialty, LLC, a for-profit limited liability company and subsidiary of Centene Corporation. The contract is for the delivery of TARPEYO (budesonide) 4mg prescription medication to the New York Harbor. The contract is a firm fixed-price purchase order with a completion date of May 28, 2025. This contract does not have a...
This is a $10,897.20 firm fixed price purchase order awarded by the Department of Veterans Affairs Veterans Health Administration to Pantherx Specialty, LLC, a specialty pharmacy subsidiary of Centene Corporation. The contract is for the supply of TARPEYO 4MG CAPSULES, a medication used to treat rare diseases, to various VA healthcare facilities under the Veterans Integrated Service Network 2. Pantherx Specialty has received multiple federal purchase orders from the Department of Veterans...
This federal contract award is for the supply of TARPEYO 4MG drug prescriptions to the New York Harbor Healthcare System, a division of the Department of Veterans Affairs (VA). The $10,897.20 firm fixed price purchase order was awarded to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. Pantherx Specialty is a specialized pharmacy focused on rare diseases and customized medications, and has established itself as a targeted provider of...
The U.S. Department of Veterans Affairs (VA) awarded a $10,897.20 firm fixed price purchase order contract to Pantherx Specialty, LLC, a specialty pharmacy focused on rare diseases, to provide the drug TARPEYO (budesonide) 4mg for an emergency requirement at the New York Harbor VA healthcare facilities. The contract has an ultimate completion date of March 5, 2025. No set-aside designation was used for this award. Pantherx Specialty, a subsidiary of Centene Corporation, is an experienced...
The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price purchase order to Pantherx Specialty LLC, doing business as Pantherx Specialty Pharmacy, to provide the pharmaceutical product Ruzurgi [amifampridine] to Veterans Integrated Service Network 16 facilities. The contract has a potential value of $119,339.01 and a completion date of September 30, 2020. Pantherx Specialty is a subsidiary of Centene Corporation that operates as a specialty pharmacy focused...
This federal contract award is for the delivery of TARPEYO, a specialized pharmaceutical product, to the Department of Veterans Affairs (VA). The prime contractor, Calliditas Therapeutics US Inc., is a foreign-owned, for-profit pharmaceutical company that has established itself as a key supplier of TARPEYO to VA medical centers and clinics nationwide. The contract, awarded on March 12, 2024, is a delivery order under Calliditas Therapeutics US Inc.'s Federal Supply Schedule (FSS) contract for...
This federal contract award, with a ceiling value of $85,242.15, was issued by the Department of Veterans Affairs Veterans Integrated Service Network 16 to Pantherx Specialty, LLC, a specialty pharmacy subsidiary of Centene Corporation. The contract is a firm fixed price purchase order for the supply of the drug Ruzurgi (amifampridine 10mg) to VA facilities within VISN 16. This contract supports the medical needs of veterans obtaining care through the VA health system. No set-aside designation...
This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 16 to Pantherx Specialty, LLC, a subsidiary of Centene Corporation, to provide the drug Ruzurgi 10mg. The contract has a ceiling value of $85,242.15 and an ultimate completion date of February 13, 2022. No set-aside designation was used for this award. Pantherx Specialty, a specialty pharmacy focused on rare diseases, has received multiple federal contracts from the...